USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still’s Disease in Elderly Patients
暂无分享,去创建一个
P. Fenaux | M. Sébert | A. Aouba | J. Rossignol | L. Drevon | A. Mékinian | N. Belfeki | L. Sailler | J. Razanamahery | S. Georgin-lavialle | M. Mahévas | P. Hirsch | T. Quéméneur | S. Miranda | D. Roos‐Weil | J. Graveleau | A. Sevoyan | Y. Hakobyan | L. Terriou | G. Maigné | M. Groh | A. Oganesyan | F. Malard | M. Décamp | M. Delplanque | D. Roos-Weil
[1] D. Kastner,et al. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. , 2021, Blood advances.
[2] E. Clappier,et al. Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune disease , 2021, Leukemia.
[3] A. Hoischen,et al. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of VEXAS patients. , 2021, The Journal of allergy and clinical immunology.
[4] C. Haas,et al. Adult onset Still’s disease in the elderly: a case-based literature review , 2021, BMC Rheumatology.
[5] D. Kastner,et al. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS , 2021, Arthritis & rheumatology.
[6] J. Maciejewski,et al. Vacuolization of hematopoietic precursors: an enigma with multiple etiologies , 2021, Blood.
[7] F. Delhommeau,et al. VEXAS syndrome: still expanding the clinical phenotype. , 2021, Rheumatology.
[8] F. Barraco,et al. Therapeutic options in Vexas syndrome: insights from a retrospective series. , 2021, Blood.
[9] E. Clappier,et al. MDS/CMML with TET2 or IDH mutation Are Associated with Systemic Inflammatory and Autoimmune Diseases (SIAD) and T Cell Dysregulation , 2020 .
[10] J. Mullikin,et al. Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease. , 2020, The New England journal of medicine.
[11] M. King,et al. Hiding in Plain Sight - Somatic Mutation in Human Disease. , 2020, The New England journal of medicine.
[12] M. Buch,et al. Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease , 2020, RMD Open.
[13] M. Kawano,et al. Elderly-onset Still's Disease Complicated by Macrophage Activation Syndrome: A Case Report and Review of the Literature , 2019, Internal medicine.
[14] M. van Gijn,et al. Next generation sequencing panel in undifferentiated autoinflammatory diseases identify patients with colchicine-responder recurrent fevers. , 2019, Rheumatology.
[15] Y. Shoenfeld,et al. A comprehensive review on adult onset Still's disease. , 2018, Journal of autoimmunity.
[16] P. Fenaux,et al. Autoimmune manifestations associated with myelodysplastic syndromes , 2018, Annals of Hematology.
[17] J. Pouchot,et al. Validation of the Fautrel classification criteria for adult-onset Still's disease. , 2018, Seminars in arthritis and rheumatism.
[18] Mario Cazzola,et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.
[19] M. McDermott,et al. Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology. , 2016, JCI insight.
[20] D. Solmaz,et al. Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort. , 2016, Journal of autoimmunity.
[21] O. Decaux,et al. Efficacy of Azacitidine in Autoimmune and Inflammatory Disorders associated with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Running title : Azacitidine in autoimmune disorders associated with MDS / CMML , 2018 .
[22] G. Schett,et al. Adult onset Still's disease associated with malignancy-Cause or coincidence? , 2016, Seminars in arthritis and rheumatism.
[23] E. Lee,et al. Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome , 2016, Medicine.
[24] J. Piette,et al. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. , 2016, Rheumatology.
[25] R. Ravazzolo,et al. Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases , 2015, Annals of the rheumatic diseases.
[26] L. Gensler,et al. Updates in adult-onset Still disease: Atypical cutaneous manifestations and associations with delayed malignancy. , 2015, Journal of the American Academy of Dermatology.
[27] S. Scholl,et al. Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5‐azacytidine and literature review , 2014, European journal of haematology.
[28] A. Fauchais,et al. [Adult-onset Still's disease as a manifestation of malignancy: report of a patient with melanoma and literature review]. , 2014, La Revue de medecine interne.
[29] É. Liozon,et al. Pseudomaladie de Still et néoplasie : une observation de mélanome et revue de la littérature , 2013 .
[30] Luca Malcovati,et al. Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.
[31] O. Fain,et al. Manifestations systémiques et auto-immunes des syndromes myélodysplasiques , 2011 .
[32] P. Fenaux,et al. [Systemic and autoimmune manifestations in myelodysplastic syndromes]. , 2011, La Revue de medecine interne.
[33] D. Henrion,et al. Systemic and immune manifestations in myelodysplasia: A multicenter retrospective study , 2011, Arthritis care & research.
[34] P. Nguyen,et al. Myelodysplastic syndromes , 2009, Nature Reviews Disease Primers.
[35] K. Akashi,et al. Longstanding Remission of Adult Onset Still’s Disease Under Imatinib Therapy in a Patient with Chronic Myelogenous Leukemia , 2009, The Journal of Rheumatology.
[36] J. Hayashi,et al. Chronic myelogenous leukemia that occurred two years after the diagnosis of adult Still's disease. , 2005, Internal medicine.
[37] K. Matsuo,et al. A case of adult-onset Still's disease complicated by non-Hodgkin's lymphoma , 2000, Lupus.
[38] M. Tanigawa,et al. A case of myelodysplastic syndrome progressing to acute myelocytic leukemia in which adult-onset Still's disease had occurred 6 years before. , 1993, International journal of hematology.
[39] L. Cavazzini,et al. Immunoblastic malignant lymphoma in adult onset Still's disease. , 1993, The Journal of rheumatology.
[40] M. Akizuki,et al. Preliminary criteria for classification of adult Still's disease. , 1992, The Journal of rheumatology.